FOR IMMEDIATE RELEASE
Continuing Medical Education Credits
Alpha-1 Foundation Continuing Medical Education Series
This series is designed to advance the knowledge and improve the diagnostic and treatment competence of healthcare providers caring for patients with Alpha-1 Antitrypsin Deficiency (Alpha-1).
The Alpha-1 Foundation Professional Education CME Program is a collection of 16, 30-minute webcasts that are available on demand. Healthcare providers will be able to obtain a total of 8 credits towards their Continuing Medical Education by completing this program. Each webcast offers 0.5 CME credits. The Foundation has partnered with the Cleveland Clinic on this new CME program. The Cleveland Clinic is serving as the program’s accrediting body. The CME program is being offered free of charge. CLICK HERE to Access Course through Cleveland Clinic Center for Continuing Education
Alpha-1 Antitrypsin Deficiency is a rare disease that is often misdiagnosed. As a result, patients can go a long time without receiving the proper care or treatment causing their condition to deteriorate more rapidly than if the care or treatment had been provided sooner. At least 100,000 Americans have Alpha-1.
Learning Objectives (but not limited to)
- Apply current guidelines and recommendations for Alpha-1 Antitrypsin Deficiency testing and diagnosis
- Apply treatment options for Alpha-1 Antitrypsin Deficiency
The professional education program will target various types of healthcare professionals, including, pulmonologists, hepatologists, pediatric lung and liver physicians, liver and lung transplant physicians, nurse practitioners, physician assistants, genetics counselors, respiratory therapists, and internal medicine/general medicine physicians. These activities have been approved for AMA PRA Category 1 Credits™ . Patients and caregivers are welcome to view the videos but no credits will be given.
A Patient’s Voice
Each video, as part of this series, includes a patient testimonial about their Alpha-1 experience.
If you have any questions about the CME program, please contact Joy Collins at email@example.com
About the Alpha-1 Foundation
Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic (inherited) condition that is passed from parents to their children through their genes. Alpha-1 may result in serious lung disease in adults and/or liver disease at any age. The Alpha-1 Foundation, founded in 1995, is committed to finding a cure for Alpha-1 and to improving the lives of people affected by Alpha-1 worldwide. The Foundation has invested over $91 million to support Alpha-1 research and programs at 128 institutions in North America, Europe, South America, the Middle East, and Australia.
Contact: Jeanne Kushner
Director of Communications & Public Affairs
877-228-7321, ext. 204